pI: 8.7463 |
Length (AA): 536 |
MW (Da): 57948 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 535 | 1ju2 (A) | 23 | 513 | 20.00 | 0 | 1 | 1.07 | -0.24 |
2 | 535 | 1gpe (A) | 22 | 579 | 20.00 | 0 | 1 | 1.08 | -0.5 |
3 | 535 | 1gpe (A) | 23 | 579 | 21.00 | 0 | 1 | 1.18 | -0.48 |
1 | 535 | 3red (A) | 23 | 514 | 18.00 | 0 | 1 | 1.04463 | 0.78 |
5 | 37 | 1onf (A) | 2 | 32 | 61.00 | 0.8 | 0.9 | 0.501367 | 1.93 |
5 | 55 | 1kf6 (A) | 5 | 55 | 31.00 | 0 | 0.29 | 0.226649 | 1.82 |
6 | 536 | 4ha6 (A) | 19 | 521 | 32.00 | 0 | 1 | 1.27747 | 0.16 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_126713)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G14185 | glucose-methanol-choline oxidoreductase-like protein |
Arabidopsis thaliana | AT3G56060 | Glucose-methanol-choline (GMC) oxidoreductase family protein |
Arabidopsis thaliana | AT1G14190 | glucose-methanol-choline oxidoreductase-like protein |
Arabidopsis thaliana | AT1G73050 | Glucose-methanol-choline (GMC) oxidoreductase family protein |
Arabidopsis thaliana | AT5G51930 | Glucose-methanol-choline (GMC) oxidoreductase family protein |
Arabidopsis thaliana | AT5G51950 | Glucose-methanol-choline (GMC) oxidoreductase family protein |
Brugia malayi | Bm1_39805 | GMC oxidoreductase family protein |
Caenorhabditis elegans | CELE_C34C6.4 | Protein C34C6.4 |
Dictyostelium discoideum | DDB_G0287229 | choline dehydrogenase |
Drosophila melanogaster | Dmel_CG45065 | CG45065 gene product from transcript CG45065-RA |
Drosophila melanogaster | Dmel_CG45064 | CG45064 gene product from transcript CG45064-RA |
Drosophila melanogaster | Dmel_CG12398 | CG12398 gene product from transcript CG12398-RA |
Drosophila melanogaster | Dmel_CG9503 | CG9503 gene product from transcript CG9503-RA |
Drosophila melanogaster | Dmel_CG9518 | CG9518 gene product from transcript CG9518-RA |
Drosophila melanogaster | Dmel_CG9514 | CG9514 gene product from transcript CG9514-RA |
Escherichia coli | b0311 | choline dehydrogenase, a flavoprotein |
Homo sapiens | 55349 | choline dehydrogenase |
Leishmania braziliensis | LbrM.35.3450 | oxidoreductase, putative |
Leishmania donovani | LdBPK_363380.1 | oxidoreductase, putative |
Leishmania infantum | LinJ.36.3380 | oxidoreductase, putative |
Leishmania major | LmjF.36.3230 | oxidoreductase, putative |
Leishmania mexicana | LmxM.36.3230 | oxidoreductase, putative |
Loa Loa (eye worm) | LOAG_03547 | GMC oxidoreductase |
Mus musculus | ENSMUSG00000015970 | choline dehydrogenase |
Mycobacterium tuberculosis | Rv1279 | Probable dehydrogenase FAD flavoprotein GMC oxidoreductase |
Mycobacterium ulcerans | MUL_4004 | dehydrogenase fad flavoprotein GMC oxidoreductase |
Neospora caninum | NCLIV_057150 | hypothetical protein |
Oryza sativa | 9266710 | Os06g0656000 |
Oryza sativa | 4349162 | Os10g0524500 |
Oryza sativa | 4336725 | Os04g0573100 |
Oryza sativa | 9271148 | Os03g0118700 |
Oryza sativa | 4330311 | Os02g0678300 |
Onchocerca volvulus | OVOC5096 | Choline dehydrogenase, mitochondrial homolog |
Schistosoma japonicum | Sjp_0075460 | IPR005834,Haloacid dehalogenase-like hydrolase,domain-containing |
Schistosoma japonicum | Sjp_0213850 | Conserved hypothetical protein |
Schistosoma japonicum | Sjp_0075450 | ko:K00108 choline dehydrogenase [EC1.1.99.1], putative |
Schistosoma japonicum | Sjp_0105830 | ko:K00108 choline dehydrogenase [EC1.1.99.1], putative |
Schistosoma japonicum | Sjp_0315030 | Choline dehydrogenase, mitochondrial precursor, putative |
Schistosoma mansoni | Smp_094500 | choline dehydrogenase |
Schmidtea mediterranea | mk4.009633.03 | Choline dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.005893.00 | Choline dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.012411.03 | Choline dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.034907.01 | Choline dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.045332.00 | |
Schmidtea mediterranea | mk4.009633.02 | Choline dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.011185.01 | Choline dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.039386.03 | |
Schmidtea mediterranea | mk4.039478.00 | Choline dehydrogenase, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.11.10730 | oxidoreductase, putative |
Trypanosoma brucei | Tb927.11.9560 | oxidoreductase, putative |
Trypanosoma congolense | TcIL3000.11.10030 | oxidoreductase, putative |
Trypanosoma cruzi | TcCLB.511229.20 | oxidoreductase, putative |
Trypanosoma cruzi | TcCLB.511589.170 | oxidoreductase, putative |
Toxoplasma gondii | TGME49_313950 | GMC oxidoreductase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1300 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.01.1320 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.1320 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.1320 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.1320 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0311 | Escherichia coli | non-essential | goodall |
TGME49_313950 | Toxoplasma gondii | Probably non-essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.